162 related articles for article (PubMed ID: 33656528)
1. Prevalence and Persistence of Cost-Related Medication Nonadherence Among Medicare Beneficiaries at High Risk of Hospitalization.
De Avila JL; Meltzer DO; Zhang JX
JAMA Netw Open; 2021 Mar; 4(3):e210498. PubMed ID: 33656528
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and persistence of cost-related medication non-adherence before and during the COVID-19 pandemic among medicare patients at high risk of hospitalization.
Zhang JX; Meltzer DO
PLoS One; 2023; 18(8):e0289608. PubMed ID: 37643168
[TBL] [Abstract][Full Text] [Related]
3. Assessing the Importance of Factors Associated with Cost-Related Nonadherence to Medication for Older US Medicare Beneficiaries.
Gu D; Shen C
Drugs Aging; 2019 Dec; 36(12):1111-1121. PubMed ID: 31686403
[TBL] [Abstract][Full Text] [Related]
4. Cost-related Medication Nonadherence and Its Risk Factors Among Medicare Beneficiaries.
Nekui F; Galbraith AA; Briesacher BA; Zhang F; Soumerai SB; Ross-Degnan D; Gurwitz JH; Madden JM
Med Care; 2021 Jan; 59(1):13-21. PubMed ID: 33298705
[TBL] [Abstract][Full Text] [Related]
5. Developing an Integrated Longitudinal Dataset for Patient-Centered Outcome Measures in Cost-Related Medication Nonadherence.
Zhang JX; Meltzer DO
Med Care; 2023 Dec; 61(12 Suppl 2):S139-S146. PubMed ID: 37963033
[TBL] [Abstract][Full Text] [Related]
6. Recent trends in cost-related medication nonadherence among stroke survivors in the United States.
Levine DA; Morgenstern LB; Langa KM; Piette JD; Rogers MA; Karve SJ
Ann Neurol; 2013 Feb; 73(2):180-8. PubMed ID: 23436312
[TBL] [Abstract][Full Text] [Related]
7. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.
Madden JM; Graves AJ; Zhang F; Adams AS; Briesacher BA; Ross-Degnan D; Gurwitz JH; Pierre-Jacques M; Safran DG; Adler GS; Soumerai SB
JAMA; 2008 Apr; 299(16):1922-8. PubMed ID: 18430911
[TBL] [Abstract][Full Text] [Related]
8. Depression and cost-related medication nonadherence in Medicare beneficiaries.
Bambauer KZ; Safran DG; Ross-Degnan D; Zhang F; Adams AS; Gurwitz J; Pierre-Jacques M; Soumerai SB
Arch Gen Psychiatry; 2007 May; 64(5):602-8. PubMed ID: 17485612
[TBL] [Abstract][Full Text] [Related]
9. Persistent medication affordability problems among disabled Medicare beneficiaries after Part D, 2006-2011.
Naci H; Soumerai SB; Ross-Degnan D; Zhang F; Briesacher BA; Gurwitz JH; Madden JM
Med Care; 2014 Nov; 52(11):951-6. PubMed ID: 25122530
[TBL] [Abstract][Full Text] [Related]
10. Recent Trends in Cost-Related Medication Nonadherence Among Cancer Survivors in the United States.
Lee MJ; Khan MM; Salloum RG
J Manag Care Spec Pharm; 2018 Jan; 24(1):56-64. PubMed ID: 29290172
[TBL] [Abstract][Full Text] [Related]
11. Cost-related medication nonadherence and cost-saving strategies used by elderly Medicare cancer survivors.
Nekhlyudov L; Madden J; Graves AJ; Zhang F; Soumerai SB; Ross-Degnan D
J Cancer Surviv; 2011 Dec; 5(4):395-404. PubMed ID: 21800053
[TBL] [Abstract][Full Text] [Related]
12. The relationship between the low-income subsidy and cost-related nonadherence to drug therapies in Medicare Part D.
Wei II; Lloyd JT; Shrank WH
J Am Geriatr Soc; 2013 Aug; 61(8):1315-23. PubMed ID: 23889465
[TBL] [Abstract][Full Text] [Related]
13. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit.
Soumerai SB; Pierre-Jacques M; Zhang F; Ross-Degnan D; Adams AS; Gurwitz J; Adler G; Safran DG
Arch Intern Med; 2006 Sep; 166(17):1829-35. PubMed ID: 17000938
[TBL] [Abstract][Full Text] [Related]
14. Identifying patients with cost-related medication non-adherence: a big-data approach.
Zhang JX; Meltzer DO
J Med Econ; 2016 Aug; 19(8):806-11. PubMed ID: 27052465
[TBL] [Abstract][Full Text] [Related]
15. Cost-related medication nonadherence among beneficiaries with depression following Medicare Part D.
Zivin K; Madden JM; Graves AJ; Zhang F; Soumerai SB
Am J Geriatr Psychiatry; 2009 Dec; 17(12):1068-76. PubMed ID: 20104063
[TBL] [Abstract][Full Text] [Related]
16. Medicare beneficiaries and free prescription drug samples: a national survey.
Tjia J; Briesacher BA; Soumerai SB; Pierre-Jacques M; Zhang F; Ross-Degnan D; Gurwitz JH
J Gen Intern Med; 2008 Jun; 23(6):709-14. PubMed ID: 18365289
[TBL] [Abstract][Full Text] [Related]
17. Cost-related nonadherence to prescribed medication therapy among Medicare Part D beneficiaries with end-stage renal disease.
Frankenfield DL; Howell BL; Wei II; Anderson KK
Am J Health Syst Pharm; 2011 Jul; 68(14):1339-48. PubMed ID: 21719594
[TBL] [Abstract][Full Text] [Related]
18. Cost-related medication nonadherence among Medicare beneficiaries with cardiovascular disease risk factors: The role of comprehension of the Medicare programme and its prescription drug benefits.
Park C; Chang CA; Ng BP; Young GJ
J Eval Clin Pract; 2023 Feb; 29(1):136-145. PubMed ID: 35982538
[TBL] [Abstract][Full Text] [Related]
19. Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes.
Williams J; Steers WN; Ettner SL; Mangione CM; Duru OK
Med Care; 2013 Feb; 51(2):193-8. PubMed ID: 23032359
[TBL] [Abstract][Full Text] [Related]
20. Cost-Related Medication Nonadherence (CRN) on Healthcare Utilization and Patient-Reported Outcomes: Considerations in Managing Medicare Beneficiaries on Antidepressants.
Alnijadi AA; Yuan J; Wu J; Li M; Lu ZK
Front Pharmacol; 2021; 12():764697. PubMed ID: 34950029
[No Abstract] [Full Text] [Related]
[Next] [New Search]
